- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic lupus erythematosus biomarkers: the challenging quest
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume -, Issue -, Pages kew407
Publisher
Oxford University Press (OUP)
Online
2016-11-29
DOI
10.1093/rheumatology/kew407
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification
- (2016) Melissa E Munroe et al. ANNALS OF THE RHEUMATIC DISEASES
- Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti-TNF-like weak inducer of apoptosis (anti-TWEAK) monoclonal antibody
- (2016) Gerald R. Galluppi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis
- (2016) H. Ding et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study
- (2016) Tianfu Wu et al. JOURNAL OF PROTEOME RESEARCH
- Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-β1 Signaling Pathway
- (2016) Zhiqin Liu et al. MEDIATORS OF INFLAMMATION
- Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis
- (2016) Tianfu Wu et al. PLoS One
- Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus
- (2016) Chi Chiu Mok et al. ARTHRITIS CARE & RESEARCH
- Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture
- (2016) Marta E. Alarcón-Riquelme et al. Arthritis & Rheumatology
- Interleukin 1, Interleukin 6, Interleukin 10, and Tumor Necrosis Factor α in Active and Quiescent Systemic Lupus Erythematosus
- (2016) Alessandro Cigni et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Thrombotic Microangiopathy in Systemic Lupus Erythematosus: Efficacy of Eculizumab
- (2015) Amr El-Husseini et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
- (2015) Kenneth C Kalunian et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis
- (2015) Sahar M. Abdel Galil et al. CYTOKINE
- Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
- (2015) Roba M. Talaat et al. CYTOKINE
- Association between IL-21 polymorphism and systemic lupus erythematosus: a meta-analysis
- (2015) J.H. Qi et al. GENETICS AND MOLECULAR RESEARCH
- Fundamental role of C1q in autoimmunity and inflammation
- (2015) Myoungsun Son et al. IMMUNOLOGIC RESEARCH
- Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome
- (2015) Thomas A. Zikos et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Angiostatin prevents IL-1β-induced down-regulation of eNOS expression by inhibiting the NF-κB cascade
- (2015) Yasushi Kawasaki et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus
- (2015) A. J. Steiman et al. JOURNAL OF RHEUMATOLOGY
- Treatment of systemic lupus erythematosus patients with the BAFF antagonist “peptibody” blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials
- (2015) William Stohl et al. ARTHRITIS RESEARCH & THERAPY
- Mechanisms of Kidney Injury in Lupus Nephritis – the Role of Anti-dsDNA Antibodies
- (2015) Susan Yung et al. Frontiers in Immunology
- A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
- (2014) R A Furie et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
- (2014) David Isenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Complement Deficiencies in Systemic Lupus Erythematosus
- (2014) Angela R. Bryan et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Type I Interferon in the Pathogenesis of Lupus
- (2014) M. K. Crow JOURNAL OF IMMUNOLOGY
- Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome
- (2014) Andreas Kronbichler et al. MEDICINE
- Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy
- (2014) Rosanna Coppo et al. PEDIATRIC NEPHROLOGY
- A Case of Thrombotic Microangiopathy Associated With Antiphospholipid Antibody Syndrome Successfully Treated With Eculizumab
- (2014) Omid Bakhtar et al. TRANSPLANTATION
- Proinflammatory Adaptive Cytokine and Shed Tumor Necrosis Factor Receptor Levels Are Elevated Preceding Systemic Lupus Erythematosus Disease Flare
- (2014) Melissa E. Munroe et al. Arthritis & Rheumatology
- Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
- (2013) Michelle A. Petri et al. ARTHRITIS AND RHEUMATISM
- Sifalimumab, a Human Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study
- (2013) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Targeting the complement system in systemic lupus erythematosus and other diseases
- (2013) Maria-Louise Barilla-LaBarca et al. CLINICAL IMMUNOLOGY
- Elevated Subclinical Double-Stranded DNA Antibodies and Future Proliferative Lupus Nephritis
- (2013) S. W. Olson et al. Clinical Journal of the American Society of Nephrology
- Glucocorticoid downregulates expression of IL-12 family cytokines in systemic lupus erythematosus patients
- (2013) F Qiu et al. LUPUS
- Urinary Angiostatin - A Novel Putative Marker of Renal Pathology Chronicity in Lupus Nephritis
- (2013) Tianfu Wu et al. MOLECULAR & CELLULAR PROTEOMICS
- IL-17 cytokines in immunity and inflammation
- (2013) Wei Jin et al. Emerging Microbes & Infections
- Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients
- (2013) Kichul Ko et al. Frontiers in Immunology
- Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
- (2012) William Stohl et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Serum cytokine profile in patients with active lupus nephritis
- (2012) Katrin Franzika Koenig et al. CYTOKINE
- Interleukin 21 Correlates with T Cell and B Cell Subset Alterations in Systemic Lupus Erythematosus
- (2012) B. TERRIER et al. JOURNAL OF RHEUMATOLOGY
- The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis
- (2012) D-Y Chen et al. LUPUS
- The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble versus Membrane-Bound Ligand
- (2012) C. Richter et al. MOLECULAR AND CELLULAR BIOLOGY
- Inflammation associated anemia and ferritin as disease markers in systemic lupus erythematosus
- (2012) Kamala Vanarsa et al. ARTHRITIS RESEARCH & THERAPY
- Biologic Differences Between Various Inhibitors of the BLyS/BAFF Pathway: Should We Expect Differences Between Belimumab and Other Inhibitors in Development?
- (2012) William Stohl Current Rheumatology Reports
- B lymphocyte stimulator levels in systemic lupus erythematosus: Higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels
- (2011) Lauren L. Ritterhouse et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- ADAM17: a molecular switch to control inflammation and tissue regeneration
- (2011) Jürgen Scheller et al. TRENDS IN IMMUNOLOGY
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus
- (2010) Corinna E. Weckerle et al. ARTHRITIS AND RHEUMATISM
- Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis
- (2010) T. Rubinstein et al. RHEUMATOLOGY
- Neutralization of interferon-α/β-inducible genes and downstream effect in a phase I trial of an anti-interferon-α monoclonal antibody in systemic lupus erythematosus
- (2009) Yihong Yao et al. ARTHRITIS AND RHEUMATISM
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Prevalence of Flare and Influence of Demographic and Serologic Factors on Flare Risk in Systemic Lupus Erythematosus: A Prospective Study
- (2009) M. PETRI et al. JOURNAL OF RHEUMATOLOGY
- Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus
- (2009) M Petri et al. LUPUS
- Efficacy and safety of infliximab in active SLE: a pilot study
- (2009) SS Uppal et al. LUPUS
- Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
- (2009) Jian-Wen Han et al. NATURE GENETICS
- Expression of TGFβ1 and Its Signaling Components by Peripheral Lymphocytes in Systemic Lupus Erythematosus
- (2009) Eszter Kohut et al. PATHOLOGY & ONCOLOGY RESEARCH
- Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus
- (2009) C. O. Jacob et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study
- (2009) Noa Schwartz et al. ARTHRITIS RESEARCH & THERAPY
- Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus
- (2008) J Morel et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients
- (2008) Timothy B. Niewold et al. ARTHRITIS AND RHEUMATISM
- Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis
- (2008) M. Tucci et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity
- (2008) Chun Kwok Wong et al. CLINICAL IMMUNOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci
- (2008) John B Harley et al. NATURE GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started